Department of Biopharmacy, Faculty of Pharmacy, University of Debrecen, Debrecen, Hungary; Veterans Affairs Medical Center, Endocrine, Polypeptide and Cancer Institute, Miami, FL, United States.
Department of Biopharmacy, Faculty of Pharmacy, University of Debrecen, Debrecen, Hungary.
Vitam Horm. 2023;123:1-26. doi: 10.1016/bs.vh.2023.06.004. Epub 2023 Jul 7.
The hypothalamic peptide growth hormone-releasing hormone (GHRH) stimulates the secretion of growth hormone (GH) from the pituitary through binding and activation of the pituitary type of GHRH receptor (GHRH-R), which belongs to the family of G protein-coupled receptors with seven potential membrane-spanning domains. Splice variants of GHRH-Rs (SV) in human tumors and other extra pituitary tissues were identified and their cDNA was sequenced. Among the SVs, splice variant 1 (SV1) possesses the greatest similarity to the full-length GHRH-R and remains functional by eliciting cAMP signaling and mitogenic activity upon GHRH stimulation. A large body of work have evaluated potential clinical applications of agonists and antagonists of GHRH in diverse fields, including endocrinology, oncology, cardiology, diabetes, obesity, metabolic dysfunctions, Alzheimer's disease, ophthalmology, wound healing and other applications. In this chapter, we briefly review the expression and potential function of GHRH-Rs and their SVs in various tissues and also elucidate and summarize the activation, molecular mechanism and signalization pathways of these receptors. Therapeutic applications of GHRH analogs are also discussed.
下丘脑肽生长激素释放激素(GHRH)通过与垂体型 GHRH 受体(GHRH-R)结合和激活来刺激垂体生长激素(GH)的分泌,GHRH-R 属于 G 蛋白偶联受体家族,具有七个潜在的跨膜结构域。在人类肿瘤和其他垂体外组织中鉴定出 GHRH-R 的剪接变异体(SV),并对其 cDNA 进行了测序。在 SV 中,剪接变异体 1(SV1)与全长 GHRH-R 具有最大的相似性,并通过在 GHRH 刺激下引发 cAMP 信号和有丝分裂活性而保持功能。大量工作评估了 GHRH 的激动剂和拮抗剂在包括内分泌学、肿瘤学、心脏病学、糖尿病、肥胖症、代谢功能障碍、阿尔茨海默病、眼科学、伤口愈合和其他应用在内的不同领域中的潜在临床应用。在本章中,我们简要回顾了 GHRH-R 和它们的 SV 在各种组织中的表达和潜在功能,并阐明和总结了这些受体的激活、分子机制和信号转导途径。还讨论了 GHRH 类似物的治疗应用。